Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA

    Francesca Ricci, Alessandra Tedeschi, Marco Montillo, Enrica Morra
    e2011031
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.031
    2254
    PDF: 937
    HTML: 2369
  • TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS

    Luca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, Chiara Sarlo, Luigi Di Caprio, Concetta Ditto, Federica Giannotti, Daniela Nasso, Eleonora Ceresoli, Massimiliano Postorino, Marco Refrigeri, Sergio Amadori, Adriano Venditti
    e2013032
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.032
    2801
    PDF: 1009
    HTML: 5520
  • TREATMENT WITH LOW-DOSE CYTARABINE IN ELDERLY PATIENTS (AGE 70 YEARS OR OLDER) WITH ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION EXPERIENCE

    Maël Heiblig, Mohamed Elhamri, Isabelle Tigaud, Adriana Plesa, Fiorenza Barraco, Hélène Labussière, Sophie Ducastelle, Mauricette Michallet, Franck Nicolini, Claudiu Plesa, Eric Wattel, Gilles Salles, Xavier Thomas
    e2016009
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.009
    7318
    PDF: 1497
    HTML: 1649
  • THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM

    May Basood, Howard S. Oster, Moshe Mittelman
    e2018046
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.046
    3062
    PDF: 1387
    HTML: 546
  • BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

    Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli
    e2016011
    2016-02-10
    https://doi.org/10.4084/mjhid.2016.011
    4305
    PDF: 1483
    HTML: 3619
  • INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?

    Francesco Zallio, Giulia Limberti, Marco Ladetto
    e2017035
    2017-05-01
    https://doi.org/10.4084/mjhid.2017.035
    3229
    PDF: 1010
    HTML: 2024
  • NEW INSIGHT ON EPIDEMIOLOGY AND MANAGEMENT OF BACTERIAL BLOODSTREAM INFECTION IN PATIENTS WITH HEMATOLOGICAL MALIGNACIES

    Sara Lo Menzo, Giulia la Martire, Giancarlo Ceccarelli, Mario Venditti
    e2015044
    2015-07-01
    https://doi.org/10.4084/mjhid.2015.044
    3063
    PDF: 1326
    HTML: 8233
  • MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

    Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade
    e2011045
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.045
    2840
    PDF: 848
    HTML: 6519
    Untitled: 227
    Untitled: 189
    Untitled: 205
    Untitled: 211
  • NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL

    Dimitar Efremov, Adrian Wiestner, Luca Laurenti
    e2012067
    2012-10-09
    https://doi.org/10.4084/mjhid.2012.067
    2501
    PDF: 839
    HTML: 8841
    Efremov 1: 226
    Efremov 2: 190
  • TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS

    Eleonora De Bellis, Luana Fianchi, Francesco Buccisano, Marianna Criscuolo, Luca Maurillo, Laura Cicconi, Mattia Brescini, Maria Ilaria Del Principe, Ambra Di Veroli, Adriano Venditti, Francesco Lo-Coco, Maria Teresa Voso
    e2017045
    2017-07-01
    https://doi.org/10.4084/mjhid.2017.045
    4319
    PDF: 1765
    HTML: 1107
  • EPIDEMIOLOGY OF CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE INFECTIONS IN MEDITERRANEAN COUNTRIES

    Corrado Girmenia, Martina Canichella, Alessandra Serrao
    e2016032
    2016-06-01
    https://doi.org/10.4084/mjhid.2016.032
    4943
    PDF: 1590
    HTML: 2381
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2453
    PDF: 785
    HTML: 1735
  • ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS

    Alessandro Busca, Livio Pagano
    e2016039
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.039
    4730
    PDF: 1554
    HTML: 2251
    Untitled: 209
    Untitled: 222
    Untitled: 231
    Untitled: 213
    Untitled: 217
  • INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

    Giuseppe Leone, Livio Pagano
    e2018039
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.039
    4182
    PDF: 1455
    HTML: 597
  • Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA

    Michele Puppi, Ilaria Sacchetti, Katia Mancuso, Paola Tacchetti, Lucia Pantani, ilaria Rizzello, Miriam Iezza, Marco Talarico, Enrica Manzato, Simone Masci, Roberta Restuccia, Simona Barbato, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Elena Zamagni
    e2025045
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.045
    1583
    PDF: 1211
    HTML: 214
  • NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES

    Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso
    e2010021
    2010-08-11
    https://doi.org/10.4084/mjhid.2010.021
    1968
    PDF: 750
    HTML: 696
  • PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASM

    Richard A. Larson, Michelle Le Beau
    e2011032
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.032
    2826
    PDF: 917
    HTML: 1871
  • PREVALENCE AND AETIOLOGY OF BACTEREMIA IN FEBRILE CHILDREN WITH SICKLE CELL DISEASE AT A NIGERIA TERTIARY HOSPITAL

    Biobele Jotham Brown, Hannah O Dada-Adegbola, Catherine Trippe, Olufunmilayo Olopade
    e2017039
    2017-06-20
    https://doi.org/10.4084/mjhid.2017.039
    2951
    PDF: 1240
    HTML: 1011
  • THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML

    Dr. Palmieri, Ilaria Del Principe, Dr. Maurillo, Prof. Venditti, Francesco Buccisano
    e2023051
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.051
    1618
    PDF: 807
    HTML: 165
  • NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa

    Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi
    e2019002
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.002
    6815
    PDF: 3645
    HTML: 753
  • ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Murat Akova
    e2017002
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.002
    4089
    PDF: 1240
    HTML: 1955
    Table 1: 197
  • OUTCOME OF CANDIDA PARAPSILOSIS COMPLEX INFECTIONS TREATED WITH CASPOFUNGIN IN CHILDREN

    İlker Devrim, Rana İşgüder, Hasan Ağın, Nuri Bayram, Gökhan Ceylan, Yüce Ayhan, Özlem Saraç Sandal, Ferhat Sarı, Ahu Kara, Mine Düzgöl
    e2016042
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.042
    3609
    PDF: 775
    HTML: 849
  • TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2023038
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.038
    2131
    PDF: 1694
    HTML: 378
  • CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE

    Abdulrahman Al Raizah, Fakhr Alayoubi, Galal Hassan Abdelnaby, Hazzaa Alzahrani, Majid Farraj Bakheet, Mohammed A Alskaini, Rasha Buhumaid, Sameer Al Awadhi, Sara Nooruddin Kazim, Thiagarajan Jaiganesh, Zohair Al Asiri
    e2024038
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.038
    2575
    PDF: 1184
    HTML: 107
  • HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

    Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré
    e2014050
    2014-07-01
    https://doi.org/10.4084/mjhid.2014.050
    2883
    PDF: 1360
    HTML: 3569
    Untitled: 192
    Untitled: 202
    Untitled: 177
  • THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

    Elvira Pelosi, Dr. Germana Castelli, Ugo Testa
    e2022080
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.080
    1485
    PDF: 1146
    HTML: 276
  • REAL WORLD DATA ON CHARACTERISTICS AND MANAGEMENT OF COMMUNITY PATIENTS RECEIVING ANTICOAGULATION THERAPY WHO PRESENTED WITH ACUTE BLEEDING TO THE EMERGENCY DEPARTMENT AT A REGIONAL AUSTRALIAN HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY. Anticoagulation and bleeding ?

    Fayez Hanna, Annemarie Hyppa, Ajay Prakash, Usira Vithanarachchi, Hizb U Dawar, Zar Sanga, George Olabode, Hamish Crisp, Professor Alhossain A. Khalafallah
    e2021017
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.017
    1573
    PDF: 541
    HTML: 326
  • THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT

    Paul Richardson, Jacob Laubach, Anuj Mahindra, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Noopur Raje, Nikhil Munshi, Kenneth Anderson
    e2010009
    2010-05-03
    https://doi.org/10.4084/mjhid.2010.009
    1070
    PDF: 714
    HTML: 616
  • APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Tadeusz Robak
    e2010011
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.011
    1667
    PDF: 647
    HTML: 2432
  • OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES

    Jon Salmanton-Garcia, Francesco Marchesi, Oliver A. Cornely, Jannik Stemler, Pierantonio Menna
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.022
    1068
    PDF: 1251
    Suppl. Files: 146
    HTML: 70
  • ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS

    George Petrikkos, Miranda Drogari-Apiranthitou
    e2011012
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.012
    2825
    PDF: 951
    HTML: 7334
  • ANTIFUNGAL SUSCEPTIBILITY TESTING: CURRENT ROLE FROM THE CLINICAL LABORATORY PERSPECTIVE

    Brunella Posteraro, Riccardo Torelli, Elena De Carolis, Patrizia Posteraro, Maurizio Sanguinetti
    e2014030
    2014-04-07
    https://doi.org/10.4084/mjhid.2014.030
    1973
    PDF: 1287
    HTML: 6423
  • HOW I TREAT FEBRILE NEUTROPENIA

    Marcio Nucci
    e2021025
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.025
    6641
    PDF: 3908
    HTML: 429
  • OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

    Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz
    e2012011
    2012-02-10
    https://doi.org/10.4084/mjhid.2012.011
    1103
    PDF: 544
    HTML: 1690
    Figures: 167
    Fifures Sanz: 176
    tables Sanz: 180
    Untitled: 176
  • MOLECULAR CHARACTERIZATION OF VANCOMYCIN, MUPIROCIN AND ANTISEPTIC RESISTANT STAPHYLOCOCCUS AUREUS STRAINS.

    Mahtab Hadadi, Hamid Heidari, Hadi Sedigh Ebrahim-Saraie, Mohammad Motamedifar
    e2018053
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.053
    1847
    PDF: 957
    HTML: 165
  • RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?

    Antonio Cuneo, Robin Foà
    e2019024
    2019-02-27
    https://doi.org/10.4084/mjhid.2019.024
    2684
    PDF: 1653
    HTML: 258
  • USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS

    Paola Mancino, Katia Falasca, Claudio Ucciferri, Eligio Pizzigallo, Jacopo Vecchiet
    e2010003
    2010-03-26
    https://doi.org/10.4084/mjhid.2010.003
    1095
    PDF: 519
    HTML: 824
  • NOVEL DRUGS IN FOLLICULAR LYMPHOMA

    Giuseppe Rossi, Antonella Anastasia
    e2016061
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.061
    4323
    PDF: 1491
    HTML: 1547
    Untitled: 225
  • UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS

    Brunella Posteraro, Riccardo Torelli, Elena De Carolis, Patrizia Posteraro, Maurizio Sanguinetti
    e2011002
    2011-01-03
    https://doi.org/10.4084/mjhid.2011.002
    2369
    PDF: 1393
    HTML: 1981
  • SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE

    Nicola Semeraro, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci
    e2010024
    2010-08-06
    https://doi.org/10.4084/mjhid.2010.024
    3298
    PDF: 1668
    HTML: 4487
  • THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

    Sumit Dahal, Smrity Upadhyay, Rashmi Banjade, Prajwal Dhakal, Navin Khanal, Vijaya Raj Bhatt
    e2017019
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.019
    4122
    PDF: 1946
    HTML: 1764
  • THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY

    Ercole Brusamolino, Manuel Gotti, Valeria Fiaccadori
    e2012022
    2012-04-06
    https://doi.org/10.4084/mjhid.2012.022
    2181
    PDF: 879
    HTML: 1946
  • LIGHT CHAIN AMYLOIDOSIS

    Paolo Milani, Giampaolo Merlini, Giovanni Palladini
    e2018022
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.022
    5531
    PDF: 2314
    HTML: 1326
  • DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

    Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso
    e2022030
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.030
    1376
    HTML: 418
    PDF: 822
  • INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.

    Malgorzata Mikulska, Matteo Bassetti, Sandra Ratto, Claudio Viscoli
    e2011007
    2011-01-25
    https://doi.org/10.4084/mjhid.2011.007
    2310
    PDF: 955
    HTML: 11130
  • INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER

    Caterina Giovanna Valentini, Luana Fianchi, Maria Teresa Voso, Morena Caira, Giuseppe Leone, Livio Pagano
    e2011069
    2011-12-22
    https://doi.org/10.4084/mjhid.2011.069
    3254
    PDF: 935
    HTML: 2956
  • WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

    Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi
    e2018004
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.004
    7444
    PDF: 2422
    HTML: 1733
    Table 1.: 208
    Table 2.: 217
    Table 3.: 202
    Table 4.: 200
  • INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY

    Salvatore Perrone, Gianna Maria D'Elia, Alessandro Pulsoni
    e2016006
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.006
    4443
    PDF: 1330
    HTML: 2159
  • INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund
    e2009028
    2009-12-28
    1080
    PDF: 613
    HTML: 4336
  • UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)

    José Luis Piñana, Estela Giménez, Lourdes Vázquez, María Ángeles Marcos, Manuel Guerreiro, Rafael Duarte, Ariadna Pérez, Carlos de Miguel, Ildefonso Espigado, Marta González-Vicent, María Suarez-Lledó, Irene García-Cadenas, Rodrigo Martino, Angel Cedillo, Monserrat Rovira, Rafael de la Cámara, David Navarro, Carlos Solano
    e2024065
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.065
    3923
    Suppl. Files: 1118
    PDF: 1066
    Html: 177
1 - 50 of 500 items 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy